Projects

scientific assistant
doc. PharmDr. Tomáš Rajtík, PhD.

International

Current
  • Identification & characterization of circulating mediators of liver dysfunction-induced HFpEF in MASLD patients
    Program: ERANET
    Duration: 1. 3. 2026 – 28. 2. 2029

National

Current
  • Cardiovascular effects of the novel antidiabetic/antiobesity drugs semaglutide and tirzepatide in 6- and 12-month-old male and female obese ZDF rats with type 2 diabetes
    Program: VEGA
    Duration: 1. 1. 2025 – 31. 12. 2028